Filaggrin related antibodies among the aged
- 1National Public Health Institute, Helsinki, Finland
- 2Department of Medicine, Helsinki University Hospital, Helsinki, Finland
- Correspondence to:
Professor T Palosuo, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland;
timo.palosuo{at}ktl.fi
- Accepted 3 July 2002
Abstract
Background: The mean age at onset of new cases of rheumatoid arthritis (RA) has increased markedly. Because the prevalence of false positive rheumatoid factor reactions increases with advancing age, the diagnostic value of this test has limitations among the aged.
Objective: To study the occurrence of two filaggrin related antibodies in an aged population.
Methods: The study covered 300 subjects aged 78–88 years, one of whom had RA. The sera were tested with enzyme linked immunosorbent assays (ELISAs), using filaggrin purified from human skin and citrullinated cyclic peptide (CCP) as antigens.
Results: One patient with RA was positive for both antibodies. When the cut off level for positive reactions was set at the 98th centile of healthy blood donors, 24 (8%) of the other subjects were positive for antibodies against filaggrin, but only one against CCP.
Conclusion: The test for anti-CCP antibody has better specificity than the test for antibodies against filaggrin among the aged.
- AFA, antifilaggrin antibodies
- CCP, citrullinated cyclic peptide
- HPLC, high performance liquid chromatography
- RA, rheumatoid arthritis
- RF, rheumatoid factor








